NeoGenomics would like to invite you to our Molecular Tumor Boards. During each meeting, multidisciplinary teams will have a live discussion consulting on multiple cases with expert oncologists and discuss optimal treatment plans. Previous...

NeoGenomics has reached an agreement to acquire Genoptix. Both NeoGenomics and Genoptix have a longstanding and strong commitment to meeting the unique diagnostic laboratory testing needs of hospitals, pathologists, and oncologists. We...